Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Seisser
A L Epstein

Showing results (1-10 of 130) with videos related to

Pageof 13
Sort By:
Journal of Healthcare Risk Management : the Journal of the American Society for Healthcare Risk Management|February 1, 1999
Placing the cornerstone for healthcare professionals' risk management education: an educational needs assessmentM A Seisser, A L Epstein
Journal of Healthcare Risk Management : the Journal of the American Society for Healthcare Risk Management|January 2, 1999
Risk management through staff educationM A Seisser, A L Epstein
Gene Therapy|April 17, 2009
Progress and prospects: biological properties and technological advances of herpes simplex virus type 1-based amplicon vectorsA L Epstein
Ethnology|May 28, 2010
Tolai sorcery and changeA L Epstein
Restorative Neurology and Neuroscience|May 10, 2011
HSV-1 amplicons. Advantages and disadvantages of a versatile vector systemA L Epstein
Journal of Virology|May 1, 1984
Immunobiochemical characterization with monoclonal antibodies of Epstein-Barr virus-associated early antigens in chemically induced cellsA L Epstein
Journal of Virology|October 6, 1997
Equimolar generation of the four possible arrangements of adjacent L components in herpes simplex virus type 1 replicative intermediatesD Bataille, A L Epstein
Virology|January 29, 2000
Genetic engineering of herpes simplex virus and vector genomes carrying loxP sites in cells expressing Cre recombinaseC Logvinoff, A L Epstein
DNA (Mary Ann Liebert, Inc.)|April 1, 1988
Short-term efficient expression of transfected DNA in human hematopoietic cells by electroporation: definition of parameters and use of chemical stimulatorsS Satyabhama, A L Epstein
Human Gene Therapy|February 15, 2001
A novel approach for herpes simplex virus type 1 amplicon vector production, using the Cre-loxP recombination system to remove helper virusC Logvinoff, A L Epstein
Pageof 13

Showing results (1-10 of 130) with videos related to

Sort By:
Pageof 13
Journal of Healthcare Risk Management : the Journal of the American Society for Healthcare Risk Management|February 1, 1999
Placing the cornerstone for healthcare professionals' risk management education: an educational needs assessmentM A Seisser, A L Epstein
Journal of Healthcare Risk Management : the Journal of the American Society for Healthcare Risk Management|January 2, 1999
Risk management through staff educationM A Seisser, A L Epstein
Gene Therapy|April 17, 2009
Progress and prospects: biological properties and technological advances of herpes simplex virus type 1-based amplicon vectorsA L Epstein
Ethnology|May 28, 2010
Tolai sorcery and changeA L Epstein
Restorative Neurology and Neuroscience|May 10, 2011
HSV-1 amplicons. Advantages and disadvantages of a versatile vector systemA L Epstein
Journal of Virology|May 1, 1984
Immunobiochemical characterization with monoclonal antibodies of Epstein-Barr virus-associated early antigens in chemically induced cellsA L Epstein
Journal of Virology|October 6, 1997
Equimolar generation of the four possible arrangements of adjacent L components in herpes simplex virus type 1 replicative intermediatesD Bataille, A L Epstein
Virology|January 29, 2000
Genetic engineering of herpes simplex virus and vector genomes carrying loxP sites in cells expressing Cre recombinaseC Logvinoff, A L Epstein
DNA (Mary Ann Liebert, Inc.)|April 1, 1988
Short-term efficient expression of transfected DNA in human hematopoietic cells by electroporation: definition of parameters and use of chemical stimulatorsS Satyabhama, A L Epstein
Human Gene Therapy|February 15, 2001
A novel approach for herpes simplex virus type 1 amplicon vector production, using the Cre-loxP recombination system to remove helper virusC Logvinoff, A L Epstein
Pageof 13